{"anticipatedPostingDate":"2027-09","denomUnitsSelected":"Participants","description":"An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent are events between first dose of study drug and up to 37 days after last dose that were absent before treatment or that worsened relative to pretreatment state.","reportingStatus":"NOT_POSTED","timeFrame":"From start of treatment up to 37 days after last dose of study drug (approximately up to 7.4 years)","title":"Number of Participants With Treatment Emergent Adverse Events Adverse Events (AEs)","type":"SECONDARY"}